Table 10.
Dose/Concentration | Name of Animal Model/Cell Lines | Route of Exposure | Duration of Exposure/Treatment | Results | Source |
---|---|---|---|---|---|
In Vivo | |||||
15 µM/kg b.w. Se + 75 mg/kg b.w. CUR | Wistar rats | Se-IP/CUR-orally | Se-ones(co/pre/post-treated groups)/CUR-ones (co-administration, post-treatment, pre-treatment) | ↓liver cells damage, ↓architecture changes of glomeruli and tubules, ↓iNOS |
[175] |
15 µM/kg b.w. Se + 75 mg/kg b.w. CUR | Wistar rat pups | Se-IP/CUR-orally | Se-ones(co/pre/post-treated groups)/CUR-ones (co-administration, post-treatment, pre-treatment) | ↓LPO, ↓SOD, GST, GPx, CAT, ↓GSH, vitamin C, vitamin E |
[177] |
In Vitro | |||||
100 μM Na2SeO3 + 100 μM or 200 μM CUR | Wistar Rat pups | Isolated lenses incubation in DMEM | 62 h | ↓oxidative stress, ↓cataract formation |
[176] |
Abbreviations: ↑ = increase; ↓ = decrease; CUR = curcumin; Se = selenium; IP = intraperitoneal injection; iNOS = inducible nitric oxide synthase; DMEM = Dulbecco’s modified eagle medium; SOD = superoxide dismutase; GPx = glutathione peroxidase; GST = glutathione S-transferases; GSH = glutathione; CAT = catalase; LPO = lipid peroxidation; Na2SeO3 = sodium selenite.